mhurhangee/ep-ind-claims huggingface dataset:
A system for removal of a vascular thrombus from a blood vessel of a patient, the system comprising: a thrombus extraction device including- a coring element shaft a stop shaft slidably positioned within the coring element shaft; a tip shaft, wherein the tip shaft is coaxial within a lumen defined by the coring element shaft and wherein the tip shaft is slidably positioned within the coring element shaft; a self-expanding coring element comprising a plurality of interconnected struts, the coring element having an opening at a proximal end and configured to core and separate a portion of the vascular thrombus from the blood vessel, wherein the proximal end of the coring element is coupled to a distal end of the coring element shaft; and an expandable cylindrical portion formed of a filament mesh structure configured to capture the vascular thrombus portion, wherein a proximal end of the filament mesh structure is coupled to a distal end of the interconnected struts of the coring element, wherein the distal end portion of the cylindrical portion is coupled to the tip shaft, and wherein the coring element shaft is displaceable relative to, and independently of, the tip shaft; wherein the stop shaft is displaceable with respect to the coring element shaft and the proximal end of the self-expanding coring element to move the self-expanding coring element to an expanded state. a coring element shaft a stop shaft slidably positioned within the coring element shaft; a tip shaft, wherein the tip shaft is coaxial within a lumen defined by the coring element shaft and wherein the tip shaft is slidably positioned within the coring element shaft; a self-expanding coring element comprising a plurality of interconnected struts, the coring element having an opening at a proximal end and configured to core and separate a portion of the vascular thrombus from the blood vessel, wherein the proximal end of the coring element is coupled to a distal end of the coring element shaft; and an expandable cylindrical portion formed of a filament mesh structure configured to capture the vascular thrombus portion, wherein a proximal end of the filament mesh structure is coupled to a distal end of the interconnected struts of the coring element, wherein the distal end portion of the cylindrical portion is coupled to the tip shaft, and wherein the coring element shaft is displaceable relative to, and independently of, the tip shaft; wherein the stop shaft is displaceable with respect to the coring element shaft and the proximal end of the self-expanding coring element to move the self-expanding coring element to an expanded state.
A rotating cylinder device, comprising: a belt being substantially cylindrical and having an axis line that is a rotational central line of a cylindrical casing; a plurality of plate-shaped parts disposed outside the belt and arranged symmetrically across the axis line; a plurality of link mechanisms pivotally connected to the respective plate-shaped parts, wherein one end of each of the link mechanisms is pivotally connected to one of the plate-shaped parts and the other end is provided with a moving protrusion, wherein the moving protrusions of the link mechanisms are adapted to move along a first direction parallel to the axis line; and the cylindrical casing adapted to rotate about the axis line and coupled to the moving protrusions, wherein when the cylindrical casing rotates about the axis line, the moving protrusions are driven by the cylindrical casing to move along the first direction, and the plate-shaped parts are driven by the link mechanisms to move along a second direction perpendicular to the axis line to contract the belt. a belt being substantially cylindrical and having an axis line that is a rotational central line of a cylindrical casing; a plurality of plate-shaped parts disposed outside the belt and arranged symmetrically across the axis line; a plurality of link mechanisms pivotally connected to the respective plate-shaped parts, wherein one end of each of the link mechanisms is pivotally connected to one of the plate-shaped parts and the other end is provided with a moving protrusion, wherein the moving protrusions of the link mechanisms are adapted to move along a first direction parallel to the axis line; and the cylindrical casing adapted to rotate about the axis line and coupled to the moving protrusions, wherein when the cylindrical casing rotates about the axis line, the moving protrusions are driven by the cylindrical casing to move along the first direction, and the plate-shaped parts are driven by the link mechanisms to move along a second direction perpendicular to the axis line to contract the belt.
An aircraft undercarriage including a strut that carries a steerable bottom portion (201, 223) carrying one or more wheels, and at least one steering actuator carried by the strut to steer the steerable bottom portion in selective manner, the undercarriage including a selective force transmission device characterized in that said selective force transmission device comprises a first element (1; 101; 201) and a second element (2; 102; 202) that is mounted to move relative to the first element, a friction member (4; 104; 204) being arranged between the first element and the second element to exert a friction force between the two elements, which force presents a maximum value that depends on prestress established by a presser member (12; 112; 212), the device including control means (10, 11, 13; 110; 210) for varying the prestress imparted by the presser member to the friction member, which control means are arranged to be capable of substantially releasing the prestress imparted by the presser member so that the prestress becomes substantially zero, the device being arranged on the undercarriage in such a manner that the first element of the transmission device is constrained in turning with the steerable bottom portion, and the second element of the transmission device is constrained in turning with a portion of the undercarriage that is actuated by the steering actuator.
An oil-and-fat composition, comprising 30 to 80 wt% of oil-and-fat and 20 to 70 wt% of oil-and-fat, wherein the oil-and-fat is an oil-and-fat comprising 70 wt% or more of StOSt and arachidic acid at a content of not more than 5 wt% relative to constituent fatty acid in the oil-and-fat, and the oil-and-fat is an oil-and-fat comprising 60 wt% or more of POP, and wherein SOS triglyceride content in the oil-and-fat composition is 80 wt% or more, StOSt content in the oil-and-fat composition is 30 wt% or more, POP content in the oil-and-fat composition is 10 wt% or more, a ratio of StLSt/StOSt in the oil-and-fat composition is 0.08 or less, a ratio of StStO/StOSt in the oil-and-fat composition is 0.03 or less, a ratio of PLP/POP in the oil-and-fat composition is 0.15 or less and a ratio of PPO/POP in the oil-and-fat composition is 0.10 or less, and wherein S represents saturated fatty acid having C16 to C22, St represents stearic acid, P represents palmitic acid, L represents linoleic acid and O represents oleic acid, and SOS represents a triglyceride in which fatty acids at 1,3-positions are S and fatty acid at 2-position is O, StOSt represents a triglyceride in which fatty acids at 1,3-positions are St and fatty acid at 2-position is O, StLSt represents a triglyceride in which fatty acids at 1,3-positions are St and fatty acid at 2-position is L, StStO represents a triglyceride in which fatty acids at 1,2-positions or 2,3-positions are St and fatty acid at 3-position or 1-position is O, POP represents a triglyceride in which fatty acids at 1,3-positions are P and fatty acid at 2-position is O, PPO represents a triglyceride in which fatty acids at 1,2-positions or 2,3-positions are P and fatty acid at 3-position or 1-position is O and PLP represents a triglyceride in which fatty acids at 1,3-positions are P and fatty acid at 2-position is L.
An apparatus for manufacture of tobacco industry products, the apparatus comprising a rolling unit comprising: a rotatable drum having a plurality of flutes extending in an axial direction of the drum and spaced circumferentially around a curved outer surface of the drum, the flutes being formed in the curved outer surface of the drum to receive axially-aligned components (5, 6) of a tobacco industry product; a roll hand having a contact surface facing and spaced from the outer surface of the drum to define a space, between the contact surface and the outer surface, within which space components of a tobacco industry product are rollable across the outer surface upon rotation of the drum; and a kicker bar disposed adjacent to the roll hand and having a contact edge facing and spaced from the outer surface of the drum; wherein the curved drum outer surface includes a groove extending in a substantially circumferential direction of the drum between the circumferentially adjacent flutes and configured to at least partially receive one or more of the tobacco industry product components as the drum rotates. a rotatable drum having a plurality of flutes extending in an axial direction of the drum and spaced circumferentially around a curved outer surface of the drum, the flutes being formed in the curved outer surface of the drum to receive axially-aligned components (5, 6) of a tobacco industry product; a roll hand having a contact surface facing and spaced from the outer surface of the drum to define a space, between the contact surface and the outer surface, within which space components of a tobacco industry product are rollable across the outer surface upon rotation of the drum; and a kicker bar disposed adjacent to the roll hand and having a contact edge facing and spaced from the outer surface of the drum; wherein the curved drum outer surface includes a groove extending in a substantially circumferential direction of the drum between the circumferentially adjacent flutes and configured to at least partially receive one or more of the tobacco industry product components as the drum rotates.
Zilucoplan for use in a method of treating amyotrophic lateral sclerosis in a subject, the method comprising administering zilucoplan to the subject.
An intervertebral implant for implantation in a treated area of an intervertebral space between vertebral bodies of a spine, wherein said implant comprises: - a spacer portion having, - an inferior and superior surface, wherein the inferior and superior surfaces each have a contact area capable of engaging with anatomy in the treated area, and the inferior and superior surfaces define a through-hole extending through the spacer body; - screw holes extending from a side portion to the inferior and superior surfaces of the spacer portion; - a plate portion rigidly coupled to the spacer portion through a coupling means (20, 22), wherein the plate portion contains screws holes for receiving screws; and - wherein a screw back out prevention mechanism is adapted on the plate portion and prevents the back out of screws from the screw holes and secures the plate portion to the spacer portion characterised in that - the coupling means comprises a pin screw provided on the plate portion to capture the sides of both of the at least two screws of the implant preventing the screws from backing out. - a spacer portion having, - an inferior and superior surface, wherein the inferior and superior surfaces each have a contact area capable of engaging with anatomy in the treated area, and the inferior and superior surfaces define a through-hole extending through the spacer body; - screw holes extending from a side portion to the inferior and superior surfaces of the spacer portion; - a plate portion rigidly coupled to the spacer portion through a coupling means (20, 22), wherein the plate portion contains screws holes for receiving screws; and - wherein a screw back out prevention mechanism is adapted on the plate portion and prevents the back out of screws from the screw holes and secures the plate portion to the spacer portion characterised in that - the coupling means comprises a pin screw provided on the plate portion to capture the sides of both of the at least two screws of the implant preventing the screws from backing out.
A method for decoding comprising: receiving at least one codeword sent over a multiple-input multiple-output, MIMO, channel, wherein the at least one codeword comprises a plurality of layers, each layer comprising a constellation point of a plurality of candidate constellation points; wherein each layer comprises a stage of a trellis and each constellation point comprises a state of one stage of the trellis; for each layer, computing a state cost metric using said codeword for each constellation point of the at least one layer, and selecting preferred states of the at least one layer whose state cost metrics meet first preferred criteria; and for each of a plurality of constellation points of said layer, computing a state cost metric using said codeword for each transition from a preferred constellation point of said layer to each constellation point of a following layer, and selecting preferred transitions to said following layer whose state cost metrics meet second preferred criteria; wherein meeting the first preferred criteria comprises being one of a candidate plurality of constellation points having the lowest state costs for a constellation point; and wherein meeting the second preferred criteria comprises being one of a candidate plurality of transitions having the lowest constellation point costs for a layer; wherein said candidate plurality is varied depending on a stage of the trellis. receiving at least one codeword sent over a multiple-input multiple-output, MIMO, channel, wherein the at least one codeword comprises a plurality of layers, each layer comprising a constellation point of a plurality of candidate constellation points; wherein each layer comprises a stage of a trellis and each constellation point comprises a state of one stage of the trellis; for each layer, computing a state cost metric using said codeword for each constellation point of the at least one layer, and selecting preferred states of the at least one layer whose state cost metrics meet first preferred criteria; and for each of a plurality of constellation points of said layer, computing a state cost metric using said codeword for each transition from a preferred constellation point of said layer to each constellation point of a following layer, and selecting preferred transitions to said following layer whose state cost metrics meet second preferred criteria; wherein meeting the first preferred criteria comprises being one of a candidate plurality of constellation points having the lowest state costs for a constellation point; and wherein meeting the second preferred criteria comprises being one of a candidate plurality of transitions having the lowest constellation point costs for a layer; wherein said candidate plurality is varied depending on a stage of the trellis.
A compound represented by general structure: wherein, - T is a water-soluble vitamin E derivative having a core chromanyl or chromanyl quinone framework and a carboxylic acid moiety substituted at the 2-position, wherein T is connected to nitrogen via the carboxylic acid moiety, as such forming an amide moiety, wherein T is represented by structure (Illa) or ( IIIb): wherein R 7 is individually a C 1 - C 6 alkyl moiety; - N* is represented by structure ( IIa) or ( IIb) - R 1 and R 2 are each independently selected from hydrogen, C 1 - C 6 alkyl or C 1 - C 6 alkenyl, or R 1 and R 2 are joined together and thus form a second linker between the amide nitrogen atom and the distal nitrogen atom, or R 1 is joined with a backbone atom of the linker L in a cyclic structure and/or R 2 is joined with a backbone atom of the linker L in a cyclic structure; - R 3 is selected from hydrogen, C 1 - C 6 alkyl or C 1 - C 6 alkenyl, wherein the alkyl or alkenyl moiety may be substituted with one or more halogen atoms, hydroxyl moieties or (halo)alkoxy moieties, or R 3 is absent when the distal nitrogen atom is part of an imine moiety; and - R 4 is selected from hydrogen or C 1 - C 6 alkyl, wherein the alkyl moiety may be substituted with one or more halogen atoms or (halo)alkoxy moieties; - X is an anion, preferably a pharmaceutically acceptable anion, for use in treating, preventing, or suppressing symptoms associated with a mitochondrial disorder or with a disease or condition associated with mitochondrial dysfunction by administration of a total daily dose in the range of 10 to 800 mg, wherein the subject to be treated does not have a concomitant medication that is known to inhibit CYP3A4 and/or PgP. - T is a water-soluble vitamin E derivative having a core chromanyl or chromanyl quinone framework and a carboxylic acid moiety substituted at the 2-position, wherein T is connected to nitrogen via the carboxylic acid moiety, as such forming an amide moiety, wherein T is represented by structure (Illa) or ( IIIb): wherein R 7 is individually a C 1 - C 6 alkyl moiety; - N* is represented by structure ( IIa) or ( IIb) - R 1 and R 2 are each independently selected from hydrogen, C 1 - C 6 alkyl or C 1 - C 6 alkenyl, or R 1 and R 2 are joined together and thus form a second linker between the amide nitrogen atom and the distal nitrogen atom, or R 1 is joined with a backbone atom of the linker L in a cyclic structure and/or R 2 is joined with a backbone atom of the linker L in a cyclic structure; - R 3 is selected from hydrogen, C 1 - C 6 alkyl or C 1 - C 6 alkenyl, wherein the alkyl or alkenyl moiety may be substituted with one or more halogen atoms, hydroxyl moieties or (halo)alkoxy moieties, or R 3 is absent when the distal nitrogen atom is part of an imine moiety; and - R 4 is selected from hydrogen or C 1 - C 6 alkyl, wherein the alkyl moiety may be substituted with one or more halogen atoms or (halo)alkoxy moieties; - X is an anion, preferably a pharmaceutically acceptable anion,
A data communication method of a terminal in a communication system, the method comprising: obtaining a list of public land mobile networks, PLMNs, supported by a base station from the base station and obtaining from the base station barring configurations for each of the PLMNs; and performing an access barring check of an access attempt for a PLMN among the PLMNs based on a barring configuration for the PLMN among the barring configurations and an access class among access classes configured in the terminal, the access class being associated with the access attempt, wherein each of the barring configurations is associated with a plurality of first barring factors, wherein each of the first barring factors is applied for a different access class among the access classes, wherein the access classes include an access class for an emergency call for which the terminal attempts access, and wherein each of the barring configurations corresponds in position to a different PLMN among the PLMNs. obtaining a list of public land mobile networks, PLMNs, supported by a base station from the base station and obtaining from the base station barring configurations for each of the PLMNs; and performing an access barring check of an access attempt for a PLMN among the PLMNs based on a barring configuration for the PLMN among the barring configurations and an access class among access classes configured in the terminal, the access class being associated with the access attempt, wherein each of the barring configurations is associated with a plurality of first barring factors, wherein each of the first barring factors is applied for a different access class among the access classes, wherein the access classes include an access class for an emergency call for which the terminal attempts access, and wherein each of the barring configurations corresponds in position to a different PLMN among the PLMNs.
An injectable composition for preventing or controlling parasitic, bacterial, or viral infections or diseases in cattle, the composition comprising: (a) an effective amount of at least one inactivated rotavirus or coronavirus viral component, (b) an effective amount of at least one macrocyclic lactone compound, wherein the macrocyclic lactone is abamectin, doramectin, eprinomectin, ivermectin, or moxidectin, (c) a suitable carrier which comprises a pharmaceutically acceptable solvent system for the macrocyclic lactone compound, said solvent system comprising dimethyl acetamide, Myglyol 840 (propylene glycol diesters of caprylic and capric acids), Span 20 (sorbitan monolaurate) and lecithin, and (d) a preservative. (a) an effective amount of at least one inactivated rotavirus or coronavirus viral component, (b) an effective amount of at least one macrocyclic lactone compound, wherein the macrocyclic lactone is abamectin, doramectin, eprinomectin, ivermectin, or moxidectin, (c) a suitable carrier which comprises a pharmaceutically acceptable solvent system for the macrocyclic lactone compound, said solvent system comprising dimethyl acetamide, Myglyol 840 (propylene glycol diesters of caprylic and capric acids), Span 20 (sorbitan monolaurate) and lecithin, and (d) a preservative.
A bifocal, non-progressive ophthalmic lens, comprising: a convex surface; a concave surface opposite the convex surface, said concave surface including: a first optical surface having a first optical power for distance vision, and a second optical surface having a second optical power for near vision, wherein the first and second optical surfaces (22, 24) are connected with each other via a contact surface which is cotangent with each of the first and second optical surfaces (22, 24), and wherein the first and second optical surfaces (22, 24) smoothly blend with the remainder of the concave surface, wherein the contact surface is centered on a line (Rc) that is a radius of the contact surface, and that extends orthogonally from the contact surface through a centroid of an intersected volume of the solids that would be defined by completions of the first and second optical surfaces (22, 24). a convex surface; a concave surface opposite the convex surface, said concave surface including: a first optical surface having a first optical power for distance vision, and a second optical surface having a second optical power for near vision, wherein the first and second optical surfaces (22, 24) are connected with each other via a contact surface which is cotangent with each of the first and second optical surfaces (22, 24), and wherein the first and second optical surfaces (22, 24) smoothly blend with the remainder of the concave surface, wherein the contact surface is centered on a line (Rc) that is a radius of the contact surface, and that extends orthogonally from the contact surface through a centroid of an intersected volume of the solids that would be defined by completions of the first and second optical surfaces (22, 24). a first optical surface having a first optical power for distance vision, and a second optical surface having a second optical power for near vision, wherein the first and second optical surfaces (22, 24) are connected with each other via a contact surface which is cotangent with each of the first and second optical surfaces (22, 24), and wherein the first and second optical surfaces (22, 24) smoothly blend with the remainder of the concave surface, wherein the contact surface is centered on a line (Rc) that is a radius of the contact surface, and that extends orthogonally from the contact surface through a centroid of an intersected volume of the solids that would be defined by completions of the first and second optical surfaces (22, 24).